See more : Koyosha Inc. (7946.T) Income Statement Analysis – Financial Results
Complete financial analysis of Daito Pharmaceutical Co.,Ltd. (4577.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Daito Pharmaceutical Co.,Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Pivotal Systems Corporation (PVS.AX) Income Statement Analysis – Financial Results
- The Hachijuni Bank, Ltd. (8359.T) Income Statement Analysis – Financial Results
- Daqin Railway Co., Ltd. (601006.SS) Income Statement Analysis – Financial Results
- HMA Agro Industries Limited (HMAAGRO.NS) Income Statement Analysis – Financial Results
- ABB Ltd (ABBNY) Income Statement Analysis – Financial Results
Daito Pharmaceutical Co.,Ltd. (4577.T)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.daitonet.co.jp
About Daito Pharmaceutical Co.,Ltd.
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.90B | 45.10B | 43.46B | 48.71B | 45.00B | 41.14B | 39.88B | 37.97B | 36.33B | 34.06B | 31.20B | 28.96B | 27.15B | 25.22B | 22.68B | 21.46B |
| Cost of Revenue | 37.06B | 34.77B | 32.01B | 37.92B | 35.51B | 32.46B | 31.77B | 30.23B | 29.10B | 26.99B | 25.21B | 23.03B | 21.49B | 20.52B | 18.98B | 17.94B |
| Gross Profit | 9.84B | 10.33B | 11.46B | 10.79B | 9.48B | 8.67B | 8.12B | 7.74B | 7.23B | 7.07B | 5.99B | 5.93B | 5.66B | 4.70B | 3.70B | 3.52B |
| Gross Profit Ratio | 20.98% | 22.91% | 26.36% | 22.16% | 21.08% | 21.08% | 20.35% | 20.39% | 19.89% | 20.76% | 19.19% | 20.47% | 20.84% | 18.64% | 16.30% | 16.42% |
| Research & Development | 2.35B | 1.87B | 1.75B | 2.03B | 1.40B | 1.61B | 1.52B | 1.27B | 1.17B | 1.18B | 890.00M | 1.11B | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.05B | 3.25B | 3.03B | 2.74B | 2.25B | 2.19B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.43B | 3.08B | 2.99B | 2.71B | 2.61B | 2.39B | 2.30B | 2.39B | 2.35B | 2.24B | 3.05B | 3.25B | 3.03B | 2.74B | 2.25B | 2.19B |
| Other Expenses | 165.00M | 3.00M | 37.00M | 28.41M | 28.76M | 28.29M | 25.82M | 47.93M | 42.74M | 40.04M | 30.02M | 25.89M | 97.60M | 80.43M | 23.00M | 51.98M |
| Operating Expenses | 5.95B | 5.12B | 4.91B | 4.88B | 4.13B | 4.12B | 3.96B | 3.91B | 3.67B | 3.55B | 3.05B | 3.25B | 3.03B | 2.74B | 2.25B | 2.19B |
| Cost & Expenses | 43.00B | 39.89B | 36.91B | 42.80B | 39.64B | 36.59B | 35.72B | 34.14B | 32.78B | 30.54B | 28.26B | 26.28B | 24.52B | 23.26B | 21.23B | 20.12B |
| Interest Income | 0.00 | 45.00M | 46.00M | 422.00K | 542.00K | 1.45M | 712.00K | 729.00K | 718.00K | 12.75M | 10.45M | 93.00K | 52.00K | 54.00K | 183.00K | 7.61M |
| Interest Expense | 41.00M | 12.00M | 9.00M | 7.85M | 11.88M | 20.90M | 24.08M | 28.57M | 39.57M | 58.45M | 87.15M | 126.28M | 158.09M | 182.27M | 219.90M | 210.05M |
| Depreciation & Amortization | 3.66B | 3.87B | 3.31B | 3.15B | 2.95B | 2.85B | 2.85B | 2.82B | 2.64B | 2.44B | 2.44B | 2.57B | 2.27B | 2.09B | 1.95B | 1.75B |
| EBITDA | 7.92B | 9.08B | 9.88B | 9.04B | 8.56B | 7.49B | 7.14B | 6.73B | 6.11B | 5.87B | 5.40B | 5.30B | 4.88B | 3.96B | 3.44B | 3.12B |
| EBITDA Ratio | 16.89% | 20.06% | 22.96% | 18.93% | 18.71% | 18.27% | 17.83% | 17.58% | 17.61% | 17.47% | 17.44% | 18.02% | 18.42% | 16.48% | 15.19% | 14.65% |
| Operating Income | 3.89B | 5.21B | 6.55B | 5.91B | 5.36B | 4.55B | 4.16B | 3.83B | 3.56B | 3.52B | 2.94B | 2.68B | 2.63B | 1.96B | 1.45B | 1.34B |
| Operating Income Ratio | 8.30% | 11.55% | 15.08% | 12.13% | 11.91% | 11.05% | 10.43% | 10.09% | 9.79% | 10.33% | 9.42% | 9.25% | 9.67% | 7.77% | 6.40% | 6.24% |
| Total Other Income/Expenses | 324.00M | -131.00M | 167.00M | -35.00M | 237.84M | 71.50M | 101.91M | 53.04M | -129.80M | -146.13M | -69.52M | -70.90M | -171.88M | -280.81M | -182.93M | -169.28M |
| Income Before Tax | 4.22B | 5.08B | 6.72B | 5.87B | 5.60B | 4.62B | 4.26B | 3.89B | 3.43B | 3.37B | 2.87B | 2.61B | 2.45B | 1.68B | 1.27B | 1.17B |
| Income Before Tax Ratio | 8.99% | 11.25% | 15.46% | 12.06% | 12.43% | 11.23% | 10.69% | 10.23% | 9.43% | 9.90% | 9.20% | 9.01% | 9.04% | 6.65% | 5.59% | 5.45% |
| Income Tax Expense | 1.04B | 1.55B | 2.09B | 1.72B | 1.67B | 1.12B | 1.25B | 1.26B | 878.70M | 1.14B | 1.06B | 821.86M | 1.07B | 687.43M | 515.61M | 476.25M |
| Net Income | 3.30B | 3.60B | 4.67B | 4.25B | 3.94B | 3.51B | 3.04B | 2.66B | 2.57B | 2.25B | 1.81B | 1.79B | 1.39B | 990.62M | 752.39M | 692.96M |
| Net Income Ratio | 7.03% | 7.98% | 10.74% | 8.72% | 8.77% | 8.54% | 7.63% | 7.00% | 7.06% | 6.59% | 5.81% | 6.17% | 5.12% | 3.93% | 3.32% | 3.23% |
| EPS | 209.99 | 227.64 | 304.90 | 282.75 | 281.51 | 255.23 | 243.10 | 212.26 | 205.07 | 183.51 | 166.58 | 176.48 | 141.00 | 100.55 | 91.15 | 105.06 |
| EPS Diluted | 209.99 | 227.45 | 304.90 | 282.75 | 279.51 | 255.23 | 243.10 | 212.26 | 205.07 | 183.51 | 166.58 | 176.48 | 141.00 | 100.55 | 91.15 | 105.06 |
| Weighted Avg Shares Out | 15.69M | 15.81M | 15.31M | 15.02M | 14.01M | 13.76M | 12.51M | 12.51M | 12.51M | 12.24M | 10.87M | 10.12M | 9.85M | 9.85M | 8.25M | 6.60M |
| Weighted Avg Shares Out (Dil) | 15.69M | 15.83M | 15.31M | 15.02M | 14.11M | 13.76M | 12.51M | 12.51M | 12.51M | 12.24M | 10.87M | 10.12M | 9.85M | 9.85M | 8.25M | 6.60M |
Source: https://incomestatements.info
Category: Stock Reports